Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial
-
- S. Petersenn
- Division of Endocrinology (S.P.), Medical Center, University of Duisburg-Essen, D-45122 Essen, Germany
-
- J. Schopohl
- Medizinische Klinik Innenstadt (J.S.), University of Munich, D-80336 Munich, Germany
-
- A. Barkan
- Division of Endocrinology (S.P.), Medical Center, University of Duisburg-Essen, D-45122 Essen, Germany
-
- P. Mohideen
- Novartis Pharmaceuticals Corporation (P.M., Y.-Y.H., K.H.), East Hanover, New Jersey 07936
-
- A. Colao
- Department of Molecular and Clinical Endocrinology and Oncology (A.C.), University Federico II, I-80125 Naples, Italy
-
- R. Abs
- Department of Endocrinology (R.A.), University of Antwerp, BE-2000 Antwerpen, Belgium
-
- A. Buchelt
- University of Michigan Medical Center (A.B.), Ann Arbor, Michigan 48109
-
- Y.-Y. Ho
- Novartis Pharmaceuticals Corporation (P.M., Y.-Y.H., K.H.), East Hanover, New Jersey 07936
-
- K. Hu
- Division of Endocrinology (S.P.), Medical Center, University of Duisburg-Essen, D-45122 Essen, Germany
-
- A. J. Farrall
- University of Edinburgh (A.J.F.), Western General Hospital, Edinburgh EH4 2XU, UK
-
- S. Melmed
- Cedars-Sinai Medical Center (S.M.), Los Angeles, California 90048
-
- B. M. K. Biller
- Neuroendocrine Clinical Center (B.M.K.B.), Massachusetts General Hospital, Boston, Massachusetts 02114
書誌事項
- 公開日
- 2010-06-01
- DOI
-
- 10.1210/jc.2009-2272
- 公開者
- The Endocrine Society
この論文をさがす
収録刊行物
-
- The Journal of Clinical Endocrinology & Metabolism
-
The Journal of Clinical Endocrinology & Metabolism 95 (6), 2781-2789, 2010-06-01
The Endocrine Society